Semi-Annual Statement Of Income

Kidswell Bio Corporation - Filing #7601153

Concept 2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
Semi-annual statement of income
Statement of income
Net sales
1,569,232,000 JPY
1,569,232,000 JPY
996,543,000 JPY
967,000,000 JPY
Cost of sales
550,357,000 JPY
550,357,000 JPY
119,571,000 JPY
103,610,000 JPY
Gross profit (loss)
1,018,875,000 JPY
1,018,875,000 JPY
876,971,000 JPY
863,390,000 JPY
Ordinary profit (loss)
-952,640,000 JPY
-968,535,000 JPY
-991,166,000 JPY
-956,432,000 JPY
Extraordinary income
418,881,000 JPY
418,881,000 JPY
JPY
JPY
Selling, general and administrative expenses
1,937,994,000 JPY
1,670,014,000 JPY
1,846,659,000 JPY
1,644,050,000 JPY
Extraordinary losses
JPY
JPY
8,513,000 JPY
43,799,000 JPY
Selling, general and administrative expenses
Depreciation
2,254,000 JPY
879,000 JPY
Operating profit (loss)
-919,118,000 JPY
-651,139,000 JPY
-969,687,000 JPY
-780,660,000 JPY
Profit (loss) before income taxes
-533,759,000 JPY
-549,653,000 JPY
-999,680,000 JPY
-1,000,232,000 JPY
Non-operating income
2,834,000 JPY
43,337,000 JPY
2,552,000 JPY
53,507,000 JPY
Income taxes - current
1,500,000 JPY
1,210,000 JPY
1,781,000 JPY
1,210,000 JPY
Non-operating income
Interest income
11,000 JPY
936,000 JPY
52,000 JPY
420,000 JPY
Income taxes
1,500,000 JPY
1,210,000 JPY
1,781,000 JPY
1,210,000 JPY
Non-operating expenses
36,356,000 JPY
360,733,000 JPY
24,031,000 JPY
229,280,000 JPY
Non-operating expenses
Interest expenses
15,460,000 JPY
15,460,000 JPY
15,688,000 JPY
15,441,000 JPY
Profit (loss)
-550,863,000 JPY
-550,863,000 JPY
-550,863,000 JPY
-535,259,000 JPY
-550,863,000 JPY
-1,001,442,000 JPY
-1,001,442,000 JPY
-1,001,461,000 JPY
-1,001,442,000 JPY
-1,001,442,000 JPY
Extraordinary income
Extraordinary losses
Impairment losses
JPY
JPY
1,449,000 JPY
92,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.